Submitted:
22 June 2024
Posted:
24 June 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Methods
2.2.1. Cardiac Catheterization
2.2.1.1. Coronary Angiography
2.2.1.2. Coronary Fractional Flow Reserve (FFR)
2.3. 13N-Ammonia PET
2.4. Evaluation Items
2.5. Statistics
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Fukazawa, R.; Kobayashi, J.; Ayusawa, M.; et al. JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease. Circ J 2020, 84, 1348–1407. [Google Scholar] [CrossRef] [PubMed]
- Pijls, N.H.J.; van Schaardenburgh, P.; Manoharan, G.; et al. Percutaneous coronary intervention of functional nonsignificant stenosis: 5-year follow up of the DEFER study. J Am Coll Cardiol 2007, 49, 2105–2111. [Google Scholar] [CrossRef] [PubMed]
- De Bruyne, B.; Piljs, N.H.J.; Kalesan, B.; et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012, 367, 991–1001. [Google Scholar] [CrossRef] [PubMed]
- van de Hoef, T.P.; van Lavieren, M.A.; Damman, P.; et al. Physiological Basis and Long-Term Clinical Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve in Coronary Stenoses of Intermediate Severity. Circ Cardiovasc Interv 2014, 7, 301–311. [Google Scholar] [CrossRef] [PubMed]
- Machac, J.; Bacharach, S.L.; Bateman, T.M.; et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006, 13, e121–151. [Google Scholar] [CrossRef] [PubMed]
- Camici, P.G.; Gropler, R.J.; Jones, T.; et al. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases. Eur Heart J 1996, 17, 25–34. [Google Scholar] [CrossRef] [PubMed]
- Murthy, V.L.; Bateman, T.M.; Beanlands, R.S.; et al. Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Med 2018, 59, 273–293. [Google Scholar] [CrossRef] [PubMed]
- Pijls, N.H.; van Son, J.A.; Kirkeeide, R.L.; De Bruyne, B.; Gould, KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993, 87, 1354–1367. [Google Scholar] [CrossRef] [PubMed]
- Ogawa, S.; Ohkubo, T.; Fukazawa, R.; et al. Estimation of myocardial hemodynamics before and after intervention in children with Kawasaki disease. J Am Coll Cardiol 2004, 43, 653–661. [Google Scholar] [CrossRef] [PubMed]
- Kern, M.J.; de Bruyne, B.; Pijls, N.H. From research to clinical practice: current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. J Am Coll Cardiol 1997, 30, 613–620. [Google Scholar] [CrossRef] [PubMed]
- Orenstein, J.M.; Shulman, S.T.; Fox, L.M.; et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 2012, 7, e38998. [Google Scholar] [CrossRef] [PubMed]
- Suzuki, A.; Miyagawa-Tomita, S.; Nakazawa, M.; et al. Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings. Jpn Heart J 2000, 41, 245–256. [Google Scholar] [PubMed]
- Gould, K.L. Does coronary flow trump coronary anatomy? JACC Cardiovasc Imaging 2009, 2, 1009–1023. [Google Scholar] [CrossRef] [PubMed]
- Manabe, O.; Naya, M.; Tamaki, N. Feasibility of PET for the management of coronary artery disease: Comparison between CFR and FFR. J Cardiol 2017, 70, 135–140. [Google Scholar] [CrossRef] [PubMed]
- Johnson, N.P.; Kirkeeide, R.L.; Gould, K.L. Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? JACC Cardiovasc Imaging 2012, 5, 193–202. [Google Scholar] [CrossRef] [PubMed]
- Tsuno, K.; Fukazawa, R.; Kiriyama, T.; et al. Peripheral Coronary Artery Circulatory Dysfunction in Remote Stage Kawasaki Disease Patients Detected by Adenosine Stress 13N-Ammonia Myocardial Perfusion Positron Emission Tomography. J Clin Med 2022, 11, 1134. [Google Scholar] [CrossRef] [PubMed]
- Gould, K.L.; Lipscomb, K.; Hamilton, G.W. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974, 33, 87–94. [Google Scholar] [CrossRef] [PubMed]






| Case | Site | AN | Stenosis | FFR | MFR | Rest MBF | Stress MBF | Collateral | Intervention | Stenosis ratio(%) |
|---|---|---|---|---|---|---|---|---|---|---|
| A | #8 | reg | - | 0.93 | 2.61 | 0.96 | 2.6 | - | - | |
| B | #2 | giant | - | 0.82 | 2.3 | 0.9 | 2.07 | - | - | |
| C | #13 | mod | - | 0.91 | 2.28 | 1.06 | 2.42 | - | - | |
| D | #7 | mod | - | 0.96 | 2.89 | 0.77 | 2.24 | - | - | |
| E | #7 | giant | - | 0.8 | 2.76 | 0.61 | 1.68 | - | - | |
| F | #12 | mod | - | 0.93 | 2.22 | 1.10 | 2.26 | - | - | |
| G | #2 | giant | - | 0.83 | 3.26 | 0.77 | 2.5 | - | - | |
| H | #2 | small | - | 0.96 | 2.19 | 1.12 | 2.45 | - | - | |
| I | #7 | mod | - | 0.95 | 2.75 | 0.8 | 2.21 | - | - | |
| J | #1 | small | - | 0.88 | 3.18 | 0.75 | 2.38 | - | - | |
| K | #7 | giant | - | 0.83 | 2.48 | 0.86 | 2.13 | - | - | |
| L | #2 | mod | - | 0.95 | 2.34 | 0.85 | 1.99 | - | - | |
| M | #9 | mod | - | 0.95 | 2.14 | 0.99 | 2.11 | - | - | |
| N | #13 | mod | - | 0.85 | 2.43 | 0.88 | 2.14 | - | - | |
| O | #4 | reg | - | 0.94 | 2.43 | 0.77 | 2.24 | - | - | |
| P | #13 | reg | - | 0.93 | 2.29 | 0.75 | 1.99 | - | - | |
| Q | #7 | giant | + | 0.6 | 1.68 | 1.02 | 1.71 | - | CABG | 90 |
| R | #8 | reg | + | 0.5 | 1.3 | 1.09 | 1.42 | - | CABG | 99 |
| S | #7 | giant | + | 0.75 | 1.67 | 1.22 | 2.05 | - | CABG | 75 |
| T | #13 | reg | - | 1.04 | 1.69 | 1.56 | 2.63 | (+)* | - | |
| U | #2 | giant | - | 0.96 | 1.83 | 1.13 | 2.08 | - | - | |
| V | #8 | reg | + | 0.44 | 2.33 | 0.94 | 2.19 | + | CABG | 99 |
| W | #7 | Giant | + | 0.73 | 2.33 | 0.95 | 2.21 | + | CABG | 90 |
| X | #11 | Giant | + | 0.55 | 2.42 | 0.69 | 1.68 | + | CABG | 99 |
| FFR | MFR | rest MBF | stress MBF | |
| Collateral (+) | 0.57±0.12 | 2.36±0.04 | 0.86±0.12 | 2.03±0.25 |
| Collateral (-) | 0.62±0.10 | 1.55±0.18 | 1.11±0.08 | 1.73±0.26 |
| P-value | 0.359 | 0.009 | 0.041 | 0.149 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).